# Aurobindo Pharma Limited - Inspection Records

Source: https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76

> Inspection records and compliance data for Aurobindo Pharma Limited in Polepally, Mahaboob Nagar, None. Access full analysis and detailed observations.

---

## Details

- Name: Aurobindo Pharma Limited
- FEI Number: 3007373532
- City: Polepally, Mahaboob Nagar
- State: None
- Country Name: India
- Address Line 1: Unit Vii, Formulation Plant, Green Industrial Park, 411/P, 425/P, 434/P, 435/P & 458/P, Plot No.S1 (Part) Sez (Pharma), Tsiic
- Zip Code: None
- Facility Type: Finished Product Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE

## Related Documents

- [483 - Aurobindo Pharma Limited - 2026-02-10](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/fa93be5a-0031-4676-b411-4813d0c7f1aa) — source: FDA, date: February 10, 2026
- [FDA Inspection 1304312 - Aurobindo Pharma Limited - 2026-02-10](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/f603cc93-dc47-4606-8cf0-0dde6af906da) — source: FDA, date: February 10, 2026
- [483 - Aurobindo Pharma Limited - 2026-01-28](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/4402f9cb-7684-4577-a119-d85aa7d6b1c3) — source: FDA, date: January 28, 2026
- [483 - Aurobindo Pharma Limited - 2022-05-10](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/cdc2cd57-b94d-4778-9f26-a81d8d0d6db3) — source: FDA, date: May 10, 2022
- [483 - Aurobindo Pharma Limited - 2022-05-10](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/32976071-2001-4f14-887c-76d96e0a30e8) — source: FDA, date: May 10, 2022
- [FDA Inspection 1169446 - Aurobindo Pharma Limited - 2022-05-10](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/b9201ac7-5ec4-46dd-8aaf-7304c3c93094) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2022
- [483 - Aurobindo Pharma Limited - 2019-09-27](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-limited/7bfb2b5e-0991-4dcb-861b-ef0d934ade3d) — source: FDA, date: September 27, 2019
- [FDA Inspection 1105823 - Aurobindo Pharma Limited - 2019-09-27](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/65ccbba1-8a36-41aa-99c4-64321edccdd9) — classification: Official Action Indicated (OAI), source: FDA, date: September 27, 2019
- [FDA Inspection 1022788 - Aurobindo Pharma Limited - 2017-06-24](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/8d9ab63f-c6f2-4237-89f8-eb13c0866d60) — classification: No Action Indicated (NAI), source: FDA, date: June 24, 2017
- [FDA Inspection 927596 - Aurobindo Pharma Limited - 2015-03-13](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/6c7e4565-5d73-4395-b181-5abaff503b71) — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2015
- [FDA Inspection 787128 - Aurobindo Pharma Limited - 2012-06-19](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/90d9c974-e3d8-49ad-961f-4caba97a4429) — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012
- [FDA Inspection 694644 - Aurobindo Pharma Limited - 2010-07-30](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/e2ec8cd8-27f8-4bb8-a70f-248992e68a88) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 30, 2010
- [FDA Inspection 636493 - Aurobindo Pharma Limited - 2009-10-13](https://www.globalkeysolutions.net/records/fda_inspections/aurobindo-pharma-limited/68cd681c-fb9d-4d3c-99bd-d99b1eb05aba) — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2009

## Related Companies

- [Pyramid Laboratories, Inc.](https://www.globalkeysolutions.net/companies/pyramid-laboratories-inc/28e777be-a530-400a-97c6-9780ede4fb33)
- [Valneva Scotland Ltd.](https://www.globalkeysolutions.net/companies/valneva-scotland-ltd/7e6970c2-c9dd-4c5d-9d35-725121b6e877)
- [Lilly del Caribe, Inc](https://www.globalkeysolutions.net/companies/lilly-del-caribe-inc/5091d4cf-a496-46ba-96aa-da9dbb686073)
- [Nippon Fine Chemical Co., Ltd.](https://www.globalkeysolutions.net/companies/nippon-fine-chemical-co-ltd/6b21c73b-4779-42c3-b0f6-64179f8de3a2)
- [Apertus Pharmaceuticals](https://www.globalkeysolutions.net/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155)
- [Chugai Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/chugai-pharmaceutical-co-ltd/5261bb2e-233a-40e3-8aa3-3e7b0b70dd29)
- [BRS Analytical Services, LLC](https://www.globalkeysolutions.net/companies/brs-analytical-services-llc/841b237e-76fe-4854-a862-802339b3e528)
- [Shionogi Pharma Co., Ltd.](https://www.globalkeysolutions.net/companies/shionogi-pharma-co-ltd/97a7893d-fd4c-45bc-9237-0e03e7d8af7c)
- [Unilever Manufacturing (US), Inc.](https://www.globalkeysolutions.net/companies/unilever-manufacturing-us-inc/ae587d51-1cf8-4ced-af22-8da0d2758cf6)
- [Sun Pharmaceutical Industries Limited](https://www.globalkeysolutions.net/companies/sun-pharmaceutical-industries-limited/286f1fa0-a9e6-4928-acc7-c3a4ef147b87)

## Related Officers

- [Jogy George](https://www.globalkeysolutions.net/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.globalkeysolutions.net/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)
- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/darren-s-brown/389a4d1f-7f34-42cd-bdc8-5bebd41aff56)
- [Research Specialist II](https://www.globalkeysolutions.net/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)